MedPath

Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis

Not Applicable
Completed
Conditions
Cystic Fibrosis
Registration Number
NCT02261987
Lead Sponsor
Universidad San Jorge
Brief Summary

This trial aims to analyze whether the resistive inspiratory manoeuvre (RIM) performed previously to autogenic drainage (AD) technique improves the effectiveness in terms of mucus clearance during a typical bronchial drainage session in adults, stable CF patients.

Detailed Description

It is a multicenter study. 4 different Spain Cystic Fibrosis Foundations are included in the study (Madrid, Valencia, Murcia and Aragón). All patients will perform three different arms of treatment in a crossover randomization. Each arm of treatment will be apply only in one session. The wash-out period will be one week. Before starting the trial, all patients will perform a control session without any intervention, only the outcome measures will be assess.

During the study period the patients' pharmacological treatment remained unchanged

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Cystic Fibrosis (CF) diagnosed ( established by genotype or sweat sodium>70 mmol/l or sweat chloride of>60 mmol/l)
  • Clinically stable at time of study entry (defined as no requirement for antibiotics or change in respiratory medication in the preceding 4 wk);
  • Chronic sputum production, at least ≥ 15 ml /24h
  • Familiar and trained in the use of autogenic drainage technique (at least 6 months) and resistive inspiratory manoeuvre (at least three previous sessions)
  • To be able to provide written, informed consent
Exclusion Criteria
  • Lung function: Forced expiratory volume in 1 second < 30 % pred . ; Forced vital capacity < 40 % pred.
  • Active haemoptysis during the previous month
  • Supplemental oxygen or non-invasive ventilation (NIV)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Wet sputum production24 hours

24h wet sputum production (g) after bronchial drainage session

Secondary Outcome Measures
NameTimeMethod
Computerized respiratory sounds30 minutes

Adventitous respiratory sounds: crackles and wheezes

Lung function (simply spirometry)30 minutes

Forced expiratory volume at 1 second, Forced vital capacity, Forced expiratory flow 25-75

Patients´ perception30 minutes

Visual analogical scale

Wet sputum production30 minutes

Wet sputum production (g) during bronchial drainage session

Trial Locations

Locations (2)

Cystic Fibrosis Association

🇪🇸

Valencia, Spain

Universidad San Jorge

🇪🇸

Zaragoza, Spain

Cystic Fibrosis Association
🇪🇸Valencia, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.